Fund shareholders of Vertex Pharmaceuticals Inc
ISIN US92532F1003 · United States · LEI 54930015RAQRRZ5ZGJ91
- Fund shareholders
- 1,205
- Of which ETFs
- 310 895 other funds
- Value held
- 56.9B $ 143.7M € · 5.3B SEK
1,205 funds hold this company. This table lists the 1,185 that declare it in a regulatory filing. The other 20 publish their holdings in their own reports. They are not in the table.
| Fund | Shares | Value | Weight in fund | |
|---|---|---|---|---|
| Capital Group U.S. Large Growth ETF Capital Group Equity ETF Trust I | 2,394 | 1.2M $ | 1.79 % | as of Feb 28, 2026 ↗ |
| WisdomTree U.S. Multifactor Fund WisdomTree Trust | 2,388 | 1.1M $ | 0.30 % | as of Mar 31, 2026 ↗ |
| JNL/DFA U.S. Core Equity Fund JNL Series Trust | 2,379 | 1.1M $ | 0.09 % | as of Mar 31, 2026 ↗ |
| Goldman Sachs JUST U.S. Large Cap Equity ETF Goldman Sachs ETF Trust | 2,367 | 1.2M $ | 0.23 % | as of Feb 28, 2026 ↗ |
| Eaton Vance Equity Strategy Fund Eaton Vance Growth Trust | 2,366 | 1.2M $ | 0.20 % | as of Feb 28, 2026 ↗ |
| Lannebo Marknad USA Lannebo Kapitalförvaltning AB | 2,360 | 10M SEK | 0.24 % | as of Mar 31, 2026 ↗ |
| Wilmington Large-Cap Strategy Fund Wilmington Funds | 2,323 | 992.8K $ | 0.16 % | as of Apr 30, 2026 ↗ |
| Xtrackers MSCI Kokusai Equity ETF DBX ETF Trust | 2,305 | 1.1M $ | 0.16 % | as of Feb 27, 2026 ↗ |
| State Street Institutional U.S. Equity Fund STATE STREET INSTITUTIONAL FUNDS | 2,301 | 1M $ | 0.32 % | as of Mar 31, 2026 ↗ |
| iShares Low Carbon Optimized MSCI ACWI ETF iShares Trust | 2,299 | 982.5K $ | 0.09 % | as of Apr 30, 2026 ↗ |
| PeakShares RMR Prime Equity ETF NORTHERN LIGHTS FUND TRUST II | 2,293 | 1.1M $ | 2.09 % | as of Feb 28, 2026 ↗ |
| CVT S&P 500 Index Portfolio Calvert Variable Trust, Inc. | 2,271 | 1M $ | 0.20 % | as of Mar 31, 2026 ↗ |
| WisdomTree Efficient Gold Plus Equity Strategy Fund WisdomTree Trust | 2,264 | 1.1M $ | 0.16 % | as of Feb 28, 2026 ↗ |
| SGI U.S. Large Cap Equity Fund RBB Fund, Inc. | 2,261 | 1.1M $ | 0.55 % | as of Feb 28, 2026 ↗ |
| Pro-Blend Conservative Term Series Manning & Napier Fund, Inc. | 2,256 | 964.2K $ | 0.35 % | as of Apr 30, 2026 ↗ |
| EQ/AB Dynamic Moderate Growth Portfolio EQ Advisors Trust | 2,232 | 996.7K $ | 0.07 % | as of Mar 31, 2026 ↗ |
| Franklin Alternative Strategies Fund Franklin Alternative Strategies Funds | 2,227 | 1.1M $ | 0.21 % | as of Feb 27, 2026 ↗ |
| First Trust Nasdaq Pharmaceuticals ETF First Trust Exchange-Traded Fund VI | 2,223 | 992.7K $ | 3.40 % | as of Mar 31, 2026 ↗ |
| Invesco S&P 500 Equal Weight Income Advantage ETF Invesco Actively Managed Exchange-Traded Fund Trust | 2,212 | 945.4K $ | 0.12 % | as of Apr 30, 2026 ↗ |
| Hartford Multifactor US Equity ETF Lattice Strategies Trust | 2,196 | 938.5K $ | 0.16 % | as of Apr 30, 2026 ↗ |
| 1290 VT Socially Responsible Portfolio EQ Advisors Trust | 2,184 | 975.2K $ | 0.38 % | as of Mar 31, 2026 ↗ |
| Boston Common ESG Impact U.S. Equity Fund Professionally Managed Portfolios | 2,177 | 972.1K $ | 1.38 % | as of Mar 31, 2026 ↗ |
| Frost Growth Equity Fund Frost Family of Funds | 2,175 | 929.6K $ | 0.43 % | as of Apr 30, 2026 ↗ |
| Gateway Equity Call Premium Fund Gateway Trust | 2,166 | 967.2K $ | 0.34 % | as of Mar 31, 2026 ↗ |
| AVIP BlackRock Advantage Large Cap Core Portfolio AuguStar Variable Insurance Products Fund Inc | 2,156 | 962.7K $ | 0.32 % | as of Mar 31, 2026 ↗ |
| Nomura VIP Balanced Series Ivy Variable Insurance Portfolios | 2,154 | 961.8K $ | 0.46 % | as of Mar 31, 2026 ↗ |
| Avanza USA Avanza Fonder AB | 2,151 | 9.2M SEK | 0.34 % | as of Mar 31, 2026 ↗ |
| Putnam Dynamic Asset Allocation Balanced Fund Putnam Asset Allocation Funds | 2,147 | 958.7K $ | 0.03 % | as of Mar 31, 2026 ↗ |
| Schwab Fundamental U.S. Broad Market ETF SCHWAB STRATEGIC TRUST | 2,146 | 1.1M $ | 0.09 % | as of Feb 28, 2026 ↗ |
| VY(R) COLUMBIA CONTRARIAN CORE PORTFOLIO Voya Partners Inc | 2,129 | 950.7K $ | 1.39 % | as of Mar 31, 2026 ↗ |
| Dynamic Allocation Fund Meeder Funds | 2,124 | 948.5K $ | 0.19 % | as of Mar 31, 2026 ↗ |
| Länsförsäkringar Sparmål 2035 Länsförsäkringar Fondförvaltning AB | 2,118 | 9M SEK | 0.06 % | as of Mar 31, 2026 ↗ |
| 1290 Avantis U.S. Large Cap Growth Fund 1290 Funds | 2,111 | 902.2K $ | 0.43 % | as of Apr 30, 2026 ↗ |
| Goldman Sachs Innovate Equity ETF Goldman Sachs ETF Trust | 2,096 | 1M $ | 0.49 % | as of Feb 28, 2026 ↗ |
| Large Company Growth Portfolio Wilshire Mutual Funds Inc | 2,094 | 935.1K $ | 0.37 % | as of Mar 31, 2026 ↗ |
| Virtus Biotech Etf ETFis Series Trust I | 2,093 | 894.5K $ | 1.51 % | as of Apr 30, 2026 ↗ |
| SIIT MULTI-ASSET REAL RETURN FUND SEI INSTITUTIONAL INVESTMENTS TRUST | 2,084 | 1M $ | 0.12 % | as of Feb 28, 2026 ↗ |
| Invesco ESG Nasdaq 100 ETF Invesco Exchange-Traded Fund Trust II | 2,084 | 1M $ | 0.63 % | as of Feb 28, 2026 ↗ |
| Federated Hermes MDT Large Cap Growth ETF Federated Hermes ETF Trust | 2,071 | 1M $ | 0.26 % | as of Feb 28, 2026 ↗ |
| SGI U.S. Large Cap Core ETF RBB Fund, Inc. | 2,061 | 1M $ | 0.66 % | as of Feb 28, 2026 ↗ |
| GraniteShares Nasdaq Select Disruptors ETF GraniteShares ETF Trust | 2,058 | 919K $ | 2.10 % | as of Mar 31, 2026 ↗ |
| KPA Blandfond Swedbank Robur Fonder AB | 2,047 | 8.7M SEK | 0.05 % | as of Mar 31, 2026 ↗ |
| Swedbank Robur Access Edge Global Swedbank Robur Fonder AB | 2,045 | 8.7M SEK | 0.13 % | as of Mar 31, 2026 ↗ |
| Rayliant Wilshire NxtGen US Large Cap Equity ETF ADVISORS' INNER CIRCLE III | 2,020 | 902K $ | 1.11 % | as of Mar 31, 2026 ↗ |
| LVIP SSGA Nasdaq-100 Index Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 2,001 | 893.5K $ | 0.63 % | as of Mar 31, 2026 ↗ |
| Goldman Sachs Global Managed Beta Fund GOLDMAN SACHS TRUST | 1,997 | 992.2K $ | 0.02 % | as of Feb 28, 2026 ↗ |
| AST Multi-Asset Diversified Portfolio Advanced Series Trust | 1,986 | 886.8K $ | 0.02 % | as of Mar 31, 2026 ↗ |
| Länsförsäkringar Sparmål 2040 Länsförsäkringar Fondförvaltning AB | 1,977 | 8.4M SEK | 0.07 % | as of Mar 31, 2026 ↗ |
| EQ/Global Equity Managed Volatility Portfolio EQ Advisors Trust | 1,970 | 879.7K $ | 0.05 % | as of Mar 31, 2026 ↗ |
| Sparrow Growth Fund SPARROW FUNDS | 1,950 | 968.8K $ | 1.41 % | as of Feb 28, 2026 ↗ |
| Invesco Russell 1000 Dynamic Multifactor ETF Invesco Exchange-Traded Self-Indexed Fund Trust | 1,941 | 964.3K $ | 0.02 % | as of Feb 28, 2026 ↗ |
| T. Rowe Price Global Growth Stock Fund T. ROWE PRICE INTERNATIONAL FUNDS, INC. | 1,936 | 827.4K $ | 0.08 % | as of Apr 30, 2026 ↗ |
| EQ/AB Dynamic Growth Portfolio EQ Advisors Trust | 1,931 | 862.3K $ | 0.09 % | as of Mar 31, 2026 ↗ |
| Columbia Global Opportunities Fund Columbia Funds Series Trust II | 1,922 | 821.4K $ | 0.26 % | as of Apr 30, 2026 ↗ |
| iShares MSCI Global Quality Factor ETF iShares Trust | 1,920 | 953.9K $ | 0.43 % | as of Feb 28, 2026 ↗ |
| Horizon Defensive Core Fund Horizon Funds | 1,904 | 946K $ | 0.20 % | as of Feb 28, 2026 ↗ |
| Columbia Variable Portfolio - Core Equity Fund Columbia Funds Variable Series Trust II | 1,903 | 849.8K $ | 0.41 % | as of Mar 31, 2026 ↗ |
| Invesco V.I. Equally-Weighted S&P 500 Fund AIM Variable Insurance Funds (Invesco Variable Insurance Funds) | 1,893 | 845.3K $ | 0.18 % | as of Mar 31, 2026 ↗ |
| State Street(R) SPDR(R) Portfolio MSCI Global Stock Market ETF SPDR INDEX SHARES FUNDS | 1,887 | 842.6K $ | 0.06 % | as of Mar 31, 2026 ↗ |
| Tema Durable Quality ETF Tema ETF Trust | 1,848 | 918.1K $ | 1.89 % | as of Feb 28, 2026 ↗ |
| Avantis U.S. Quality ETF American Century ETF Trust | 1,786 | 887.3K $ | 0.46 % | as of Feb 28, 2026 ↗ |
| ProShares S&P 500 Ex-Technology ETF ProShares Trust | 1,763 | 875.9K $ | 0.32 % | as of Feb 28, 2026 ↗ |
| PROFUND VP NASDAQ-100 ProFunds | 1,760 | 785.9K $ | 0.54 % | as of Mar 31, 2026 ↗ |
| Länsförsäkringar Sparmål 2030 Länsförsäkringar Fondförvaltning AB | 1,759 | 7.5M SEK | 0.05 % | as of Mar 31, 2026 ↗ |
| Global X Nasdaq 100 Covered Call & Growth ETF GLOBAL X FUNDS | 1,755 | 750.1K $ | 0.53 % | as of Apr 30, 2026 ↗ |
| VictoryShares US 500 Volatility Wtd ETF Victory Portfolios II | 1,743 | 778.3K $ | 0.15 % | as of Mar 31, 2026 ↗ |
| Janus Henderson Global Sustainable Equity Fund JANUS INVESTMENT FUND | 1,743 | 778.3K $ | 1.00 % | as of Mar 31, 2026 ↗ |
| Buffalo Blue Chip Growth Fund Buffalo Funds | 1,725 | 770.3K $ | 0.48 % | as of Mar 31, 2026 ↗ |
| EQ/AB Dynamic Aggressive Growth Portfolio EQ Advisors Trust | 1,714 | 765.4K $ | 0.07 % | as of Mar 31, 2026 ↗ |
| Xtrackers Net Zero Pathway Paris Aligned US Equity ETF DBX ETF Trust | 1,706 | 847.6K $ | 0.30 % | as of Feb 27, 2026 ↗ |
| The Future Fund Long/Short ETF NORTHERN LIGHTS FUND TRUST II | 1,677 | 833.2K $ | 2.11 % | as of Feb 28, 2026 ↗ |
| State Street(R) SPDR(R) MSCI World StrategicFactors(SM) ETF SPDR INDEX SHARES FUNDS | 1,626 | 726.1K $ | 0.41 % | as of Mar 31, 2026 ↗ |
| Columbia Disciplined Value Fund Columbia Funds Series Trust II | 1,616 | 690.6K $ | 0.36 % | as of Apr 30, 2026 ↗ |
| Nuveen Life Large Cap Responsible Equity Fund TIAA-CREF Life Funds | 1,613 | 720.3K $ | 0.73 % | as of Mar 31, 2026 ↗ |
| iShares MSCI USA Size Factor ETF iShares Trust | 1,611 | 688.5K $ | 0.17 % | as of Apr 30, 2026 ↗ |
| BlackRock Advantage Large Cap Core Portfolio BlackRock Series Fund, Inc. | 1,603 | 715.8K $ | 0.34 % | as of Mar 31, 2026 ↗ |
| MML Sustainable Equity Fund MML SERIES INVESTMENT FUND | 1,596 | 712.7K $ | 0.57 % | as of Mar 31, 2026 ↗ |
| AVIP BlackRock Balanced Allocation Portfolio AuguStar Variable Insurance Products Fund Inc | 1,586 | 708.2K $ | 0.21 % | as of Mar 31, 2026 ↗ |
| Empower Core Strategies: U.S. Equity Fund EMPOWER FUNDS, INC. | 1,576 | 703.7K $ | 0.10 % | as of Mar 31, 2026 ↗ |
| Länsförsäkringar Globala Mål Index Länsförsäkringar Fondförvaltning AB | 1,569 | 6.7M SEK | 0.24 % | as of Mar 31, 2026 ↗ |
| BlackRock Systematic Multi-Strategy Fund BlackRock Funds IV | 1,565 | 698.8K $ | 0.01 % | as of Mar 31, 2026 ↗ |
| Xtrackers US National Critical Technologies ETF DBX ETF Trust | 1,519 | 754.7K $ | 0.66 % | as of Feb 28, 2026 ↗ |
| AZL DFA U.S. Core Equity Fund Allianz Variable Insurance Products Trust | 1,508 | 673.4K $ | 0.09 % | as of Mar 31, 2026 ↗ |
| Invesco Russell 1000 Equal Weight ETF Invesco Exchange-Traded Fund Trust II | 1,470 | 730.3K $ | 0.09 % | as of Feb 28, 2026 ↗ |
| Victory Growth and Tax Strategy Fund Victory Portfolios III | 1,469 | 729.8K $ | 0.08 % | as of Feb 28, 2026 ↗ |
| JNL/JPMorgan Global Allocation Fund JNL Series Trust | 1,461 | 652.4K $ | 0.08 % | as of Mar 31, 2026 ↗ |
| BlackRock Advantage Large Cap Core V.I. Fund BlackRock Variable Series Funds, Inc. | 1,453 | 648.8K $ | 0.33 % | as of Mar 31, 2026 ↗ |
| NASDAQ-100(R) Fund Rydex Variable Trust | 1,453 | 648.8K $ | 0.49 % | as of Mar 31, 2026 ↗ |
| Transamerica Large Core ESG TRANSAMERICA FUNDS | 1,448 | 618.8K $ | 0.36 % | as of Apr 30, 2026 ↗ |
| Adasina Social Justice All Cap Global ETF Tidal Trust I | 1,444 | 717.4K $ | 0.26 % | as of Feb 28, 2026 ↗ |
| Growth and Income Portfolio BNY MELLON VARIABLE INVESTMENT FUND | 1,435 | 640.8K $ | 0.70 % | as of Mar 31, 2026 ↗ |
| Franklin Genomic Advancements ETF Franklin Templeton ETF Trust | 1,435 | 640.8K $ | 2.99 % | as of Mar 31, 2026 ↗ |
| Franklin Allocation VIP Fund Franklin Templeton Variable Insurance Products Trust | 1,430 | 638.6K $ | 0.12 % | as of Mar 31, 2026 ↗ |
| State Street Total Return V.I.S. Fund STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 1,419 | 633.6K $ | 0.06 % | as of Mar 31, 2026 ↗ |
| Asset Allocation Fund VALIC Co I | 1,411 | 701K $ | 0.48 % | as of Feb 28, 2026 ↗ |
| Invesco S&P 500 BuyWrite ETF Invesco Exchange-Traded Fund Trust | 1,406 | 600.9K $ | 0.18 % | as of Apr 30, 2026 ↗ |
| SGI Global Equity Fund RBB Fund, Inc. | 1,397 | 694.1K $ | 0.85 % | as of Feb 28, 2026 ↗ |
| State Street Balanced Index Fund STATE STREET INSTITUTIONAL INVESTMENT TRUST | 1,391 | 621.1K $ | 0.11 % | as of Mar 31, 2026 ↗ |
| BlackRock Advantage Global Fund, Inc. BlackRock Advantage Global Fund, Inc. | 1,380 | 616.2K $ | 0.11 % | as of Mar 31, 2026 ↗ |
| PROFUND VP HEALTH CARE ProFunds | 1,376 | 614.4K $ | 2.06 % | as of Mar 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Invesco Nasdaq Biotechnology ETF Invesco Exchange-Traded Fund Trust II | 9.30 % | as of Feb 28, 2026 ↗ |
| Direxion Daily Biotech Top 5 Bull 2X ETF Direxion Shares ETF Trust | 8.22 % | as of Apr 30, 2026 ↗ |
| VanEck Biotech ETF VanEck ETF Trust | 8.06 % | as of Mar 31, 2026 ↗ |
| iShares Biotechnology ETF iShares Trust | 7.44 % | as of Mar 31, 2026 ↗ |
| ProShares Ultra Nasdaq Biotechnology ProShares Trust | 6.27 % | as of Feb 28, 2026 ↗ |
| AlphaCentric Life Sciences and Healthcare Fund MUTUAL FUND SERIES TRUST | 5.60 % | as of Mar 31, 2026 ↗ |
| ClearBridge Growth Fund Legg Mason Partners Investment Trust | 5.44 % | as of Feb 27, 2026 ↗ |
| ClearBridge Variable Growth Portfolio Legg Mason Partners Variable Equity Trust | 5.33 % | as of Mar 31, 2026 ↗ |
| Virtus KAR Health Sciences Fund Virtus Investment Trust | 5.09 % | as of Mar 31, 2026 ↗ |
| BNP Paribas Funds Health Care Innovators BNP Paribas Asset Management Luxembourg | 4.90 % | as of Dec 31, 2025 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 1,048 | +76 | 123,815,099 | +2.9 % |
| 2026Q1 | 972 | -29 | 120,276,157 | +1.8 % |
| 2025Q4 | 1,001 | -22 | 118,183,576 | -3.6 % |
| 2025Q3 | 1,023 | -31 | 122,642,833 | +1.6 % |
| 2025Q2 | 1,054 | +33 | 120,769,763 | +3.2 % |
| 2025Q1 | 1,021 | -78 | 117,052,590 | +2.0 % |
| 2024Q4 | 1,099 | -59 | 114,791,743 | +0.8 % |
| 2024Q3 | 1,158 | -31 | 113,844,744 | +1.6 % |
| 2024Q2 | 1,189 | -2 | 112,003,751 | +5.6 % |
| 2024Q1 | 1,191 | -6 | 106,033,489 | -4.0 % |
| 2023Q4 | 1,197 | 110,442,131 |
Institutional managers
1,670 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| Capital World Investors | 25,368,124 | 11.3B $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 23,969,517 | 10.7B $ | as of Mar 31, 2026 |
| Capital Research Global Investors | 21,125,964 | 9.4B $ | as of Mar 31, 2026 |
| STATE STREET CORP | 11,730,139 | 5.2B $ | as of Mar 31, 2026 |
| JPMORGAN CHASE & CO | 7,033,156 | 3.1B $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 6,139,621 | 2.7B $ | as of Mar 31, 2026 |
| Capital International Investors | 5,126,077 | 2.3B $ | as of Mar 31, 2026 |
| LOOMIS SAYLES & CO L P | 4,003,821 | 1.8B $ | as of Mar 31, 2026 |
| ALLIANCEBERNSTEIN L.P. | 3,910,786 | 1.8B $ | as of Mar 31, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | 3,212,589 | 1.4B $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 3,188,881 | 1.4B $ | as of Mar 31, 2026 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 3,057,396 | 1.4B $ | as of Mar 31, 2026 |
| BANK OF AMERICA CORP /DE/ | 2,878,183 | 1.3B $ | as of Mar 31, 2026 |
| JENNISON ASSOCIATES LLC | 2,740,059 | 1.2B $ | as of Mar 31, 2026 |
| Clearbridge Investments, LLC | 2,700,975 | 1.2B $ | as of Mar 31, 2026 |
| AMERIPRISE FINANCIAL INC | 2,633,481 | 1.2B $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 2,564,264 | 1.1B $ | as of Mar 31, 2026 |
| Invesco Ltd. | 2,561,057 | 1.1B $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 2,417,875 | 1.1B $ | as of Mar 31, 2026 |
| JANUS HENDERSON GROUP PLC | 2,131,527 | 951.8M $ | as of Mar 31, 2026 |
| FMR LLC | 2,020,265 | 902.1M $ | as of Mar 31, 2026 |
| Legal & General Group Plc | 1,955,764 | 873.3M $ | as of Mar 31, 2026 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1,920,871 | 857.7M $ | as of Mar 31, 2026 |
| VICTORY CAPITAL MANAGEMENT INC | 1,888,521 | 843.3M $ | as of Mar 31, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 1,760,122 | 786K $ | as of Mar 31, 2026 |
Declared shareholders of Vertex Pharmaceuticals Inc
There are 3 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Capital World Investors | 10.10 % | 25,695,015 | as of Mar 31, 2026 · SCHEDULE 13G |
| Capital Research Global Investors | 8.30 % | 21,139,169 | as of Mar 31, 2026 · SCHEDULE 13G |
| Vanguard Capital Management | 7.49 % | 19,036,076 | as of Mar 31, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Fund shareholders of Vertex Pharmaceuticals Inc". https://titelia.com/en/stocks/vertex-pharmaceuticals-inc-US92532F1003